TP53 and Ewing sarcoma: It is noteworthy that ANKRD11 was recently reported as a p53 coactivator [72], suggesting that the loss of p53 activators may contribute towards the ability of Ewing Sarcomas to develop and progress in the presence of a wild-type p53.